Email
Password
Remember meForgot password?
    Log in with Twitter
Blog In Health

FDA approves obesity drug

blog:17270:2::0
By Tim Sandle
Posted Jul 3, 2012 in Health
The U.S. Food and Drug Administration has approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).
For more details, see the FDA.

blog:17270:2::0
More about Obesity, Fda, Drug